U.S., July 14 -- ClinicalTrials.gov registry received information related to the study (NCT07698197) titled 'Exercise Intervention and Immunodeficiency' on June 30.
Brief Summary: The purpose of this study is to assess if a 12-week exercise program is safe, practical, and acceptable for adults with primary antibody deficiencies. It also looks at whether the program can improve the quality of life and help the immune system work better.
Study Start Date: July, 2026
Study Type: INTERVENTIONAL
Condition:
Primary Antibody Deficiency Disorders
Intervention:
BEHAVIORAL: App-based exercise intervention
12 week structured moderate-intensity exercise intervention delivered via a mobile application
Recruitment Status: NOT_YET_RECRUITING
Spo...